In conditions other than sepsis that are associated with increased levels of cell-free hemoglobin, such as cardiopulmonary bypass, red blood cell transfusion, extracorporeal circulation, and acute hemolysis, haptoglobin has been studied in humans as a potential therapeutic to prevent morbidity and mortality [32]. Here, HP is linked to Sepsis.